Furthermore, BNIP3L-mediated mitophagy might function as a tumor promoter with the evidence that Bnip3l depletion significantly delays the progression of pancreatic cancer and improves the survival in a murine model of pancreatic ductal adenocarcinoma [77]. This evidence concerns the gene BNIP3L and pancreatic ductal adenocarcinoma.